Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 277-283 , May 2009

Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment

  • Hai-Bo Liu, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Chui-Ze Kong, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • Corresponding Author InformationCorresponding author. Tel.: +86-24-83283433; fax: +86-24-83283433
    • ,
  • Yu Zeng, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan
    • ,
  • Xian-Kui Liu, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Jian-Bin Bi, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Yuan-Jun Jiang, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Sheng Han, M.D.

      Affiliations

    • Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China

Received 28 December 2007 ,Revised 10 March 2008 ,Accepted 10 March 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00064-1

doi: 10.1016/j.urolonc.2008.03.015

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 277-283 , May 2009

Article Tools

* Image Usage & Resolution